CD19-specific CAR-T cell therapy for relapsed/refractory non-B-cell acute leukaemia with CD19 antigen expression

被引：5

作者：

Liu, Shuangyou ^{[1
]}

Yin, Zhichao ^{[1
]}

Yu, Xinjian ^{[2
]}

Zhao, Yongqiang ^{[3
]}

Pan, Jing ^{[1
]}

Song, Yanzhi ^{[3
]}

机构：

[1] Beijing Boren Hosp, Dept Hematol, 6 South Zhengwangfen,Fengtai Dist, Beijing 100070, Peoples R China

[2] Beijing Boren Hosp, Med Lab, Beijing, Peoples R China

[3] Beijing Boren Hosp, Dept Bone Marrow Transplantat, Beijing, Peoples R China

来源：

EUROPEAN JOURNAL OF CANCER | 2021年 / 153卷

关键词：

D O I：

10.1016/j.ejca.2021.04.042

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 4

页数：4

共 11 条

[1] Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies [J].

Cheng, Jiali ;

Zhao, Lei ;

Zhang, Yuanyuan ;

Qin, Yun ;

Guan, Yuqi ;

Zhang, Tong ;

Liu, Chaohong ;

Zhou, Jianfeng .

FRONTIERS IN ONCOLOGY, 2019, 9

[2] Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells [J].

Danylesko, Ivetta ;

Jacoby, Elad ;

Yerushalmi, Ronit ;

Shem-Tov, Noga ;

Besser, Michal J. ;

Vernitsky, Helly ;

Marcu-Malina, Victoria ;

Shimoni, Avichai ;

Avigdor, Abraham ;

Nagler, Arnon .

LEUKEMIA, 2020, 34 (07) :1939-1942

[3] A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy [J].

Epperly, Rebecca ;

Gottschalk, Stephen ;

Velasquez, M. Paulina .

FRONTIERS IN ONCOLOGY, 2020, 10

[4] CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies [J].

Gomes-Silva, Diogo ;

Srinivasan, Madhuwanti ;

Sharma, Sandhya ;

Lee, Ciaran M. ;

Wagner, Dimitrios L. ;

Davis, Timothy H. ;

Rouce, Rayne H. ;

Bao, Gang ;

Brenner, Malcolm K. ;

Mamonkin, Maksim .

BLOOD, 2017, 130 (03) :285-296

[5] Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML) [J].

Hofmann, Susanne ;

Schubert, Maria-Luisa ;

Wang, Lei ;

He, Bailin ;

Neuber, Brigitte ;

Dreger, Peter ;

Mueller-Tidow, Carsten ;

Schmitt, Michael .

JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)

[6]

KITA K, 1992, BLOOD, V80, P470

[7] Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia [J].

Liu, Shuangyou ;

Deng, Biping ;

Yin, Zhichao ;

Pan, Jing ;

Lin, Yuehui ;

Ling, Zhuojun ;

Wu, Tong ;

Chen, Dong ;

Chang, Alex H. ;

Gao, Zhiyong ;

Song, Yanzhi ;

Zhao, Yongqiang ;

Tong, Chunrong .

BLOOD CANCER JOURNAL, 2020, 10 (02)

[8]

Ma Gina, 2018, Leuk Res Rep, V9, P42, DOI 10.1016/j.lrr.2018.03.002

[9] Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia [J].

Maude, Shannon L. ;

Frey, Noelle ;

Shaw, Pamela A. ;

Aplenc, Richard ;

Barrett, David M. ;

Bunin, Nancy J. ;

Chew, Anne ;

Gonzalez, Vanessa E. ;

Zheng, Zhaohui ;

Lacey, Simon F. ;

Mahnke, Yolanda D. ;

Melenhorst, Jan J. ;

Rheingold, Susan R. ;

Shen, Angela ;

Teachey, David T. ;

Levine, Bruce L. ;

June, Carl H. ;

Porter, David L. ;

Grupp, Stephan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16) :1507-1517

[10] High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients [J].

Pan, J. ;

Yang, J. F. ;

Deng, B. P. ;

Zhao, X. J. ;

Zhang, X. ;

Lin, Y. H. ;

Wu, Y. N. ;

Deng, Z. L. ;

Zhang, Y. L. ;

Liu, S. H. ;

Wu, T. ;

Lu, P. H. ;

Lu, D. P. ;

Chang, A. H. ;

Tong, C. R. .

LEUKEMIA, 2017, 31 (12) :2587-2593

← 1 2 →